Clinical features and prognostic factors in thymoma and thymic carcinoma
Authors:
- 14 May 2024
- journal article
- research article
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 40 (6) , 660-668
Abstract
Introduction Thymic epithelial tumors represent the most common cause of anterior mediastinal masses in adults. Among these tumors, thymomas constitute the majority, whereas thymic carcinomas are less prevalent and associated with a poorer prognosis. This study seeks to investigate the clinical and prognostic factors of these rare entities, thymoma, and thymic carcinomas. Materials and methods We conducted a retrospective analysis on a cohort of 60 patients diagnosed with thymoma and thymic carcinoma, who were under follow-up at our clinic between January 1998 and February 2023. The clinical characteristics and prognostic factors of these patients were analyzed separately. Results Thymomas accounted for 75% of the cases. The median age at diagnosis was 46 years in both patient groups. Masaoka stage 4 was observed in 28.9% of thymoma patients and 66.7% of thymic carcinoma patients. The median overall survival (mOS) for thymoma patients was 261.4 months, while it was 9.23 months for patients with thymic carcinoma. Curative surgery emerged as a prognostic factor significantly influencing overall survival in both thymoma and thymic carcinoma patients. Conclusion Our study highlights the significance of Eastern Cooperative Oncology Group (ECOG) performance status and curative surgery as prognostic factors affecting overall survival in thymoma patients. In thymic carcinoma, only curative surgery was found as a prognostic factor. These findings may enhance patient care and guide personalized treatment strategies. Further investigations and prospective studies are warranted to corroborate and expand upon these results.Keywords
This publication has 23 references indexed in Scilit:
- Unradical Surgery for Locally-Advanced Thymoma: Is it time to evolve Perspectives?Lung Cancer, 2023
- Clinical outcomes for patients with thymoma and thymic carcinoma after undergoing different front‐line chemotherapy regimensCancer Medicine, 2022
- RECIST 1.1—Update and clarification: From the RECIST committeeEuropean Journal of Cancer, 2016
- Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2015
- Thymic carcinoma outcomes and prognosis: Results of an international analysisThe Journal of Thoracic and Cardiovascular Surgery, 2015
- Thirty-Five–Year Follow-Up Analysis of Clinical and Pathologic Outcomes of Thymoma SurgeryThe Annals of Thoracic Surgery, 2010
- Resected invasive thymoma with multiple endocrine neoplasia type 1General Thoracic and Cardiovascular Surgery, 2006
- Thymic carcinoma: state of the art reviewInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Postoperative radiotherapy in thymic carcinoma: treatment results and prognostic factorsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002
- Primary chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide in locally advanced thymomas: a single institution experienceBritish Journal of Cancer, 1999